Cytokine signature clusters as a tool to compare changes associated with tobacco product use in upper and lower airway samples.
cytokine clusters
tobacco product use
unsupervised machine learning
upper and lower airways
Journal
American journal of physiology. Lung cellular and molecular physiology
ISSN: 1522-1504
Titre abrégé: Am J Physiol Lung Cell Mol Physiol
Pays: United States
ID NLM: 100901229
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
pubmed:
24
3
2022
medline:
28
4
2022
entrez:
23
3
2022
Statut:
ppublish
Résumé
Inhalation exposure to cigarette smoke and e-cigarette aerosol is known to alter the respiratory immune system, particularly cytokine signaling. In assessments of health impacts of tobacco product use, cytokines are often measured using a variety of sample types, from serum to airway mucosa. However, it is currently unclear whether and how well cytokine levels from different sample types and the airway locations they represent are correlated, making comparing studies that utilize differing sample types challenging. To address this challenge, we compared baseline cytokine signatures in upper and lower airways and systemic samples and evaluated how groups of coexpressed cytokines change with tobacco product use. Matched nasal lavage fluid (NLF), nasal epithelial lining fluid (NELF), sputum, and circulating serum samples were collected from 14 nonsmokers, 13 cigarette smokers, and 17 e-cigarette users and analyzed for levels of 22 cytokines. Individual cytokine signatures were first compared across each sample type, followed by identification of cytokine clusters within each sample type. Identified clusters were then evaluated for potential alterations following tobacco product use using eigenvector analyses. Individual cytokine signatures in the respiratory tract were significantly correlated (NLF, NELF, and sputum) compared with randomly permutated signatures, whereas serum was not significantly different from random permutations. Cytokine clusters that were similar across airway sample types were modified by tobacco product use, particularly e-cigarettes, indicating a degree of uniformity in terms of how cytokine host defense and immune cell recruitment responses cooperate in the upper and lower airways. Overall, cluster-based analyses were found to be especially useful in small cohort assessments, providing higher sensitivity than individual signatures to detect biologically meaningful differences between tobacco use groups. This novel cluster analysis approach revealed that eigencytokine patterns in noninvasive upper airway samples simulate cytokine patterns in lower airways.
Identifiants
pubmed: 35318855
doi: 10.1152/ajplung.00299.2021
pmc: PMC9054348
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
L722-L736Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NHLBI NIH HHS
ID : P50 HL120100
Pays : United States
Organisme : NIEHS NIH HHS
ID : T32 ES007126
Pays : United States
Références
J Allergy Clin Immunol. 2012 Oct;130(4):958-67.e14
pubmed: 23021143
Environ Health Perspect. 2011 Jan;119(1):78-83
pubmed: 20920950
Front Immunol. 2019 Jun 18;10:1338
pubmed: 31275311
J Adolesc Health. 2020 Oct;67(4):519-523
pubmed: 32798097
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 5;771(1-2):221-36
pubmed: 12016001
Nanotoxicology. 2021 Aug;15(6):832-849
pubmed: 33961536
Thorax. 2018 Dec;73(12):1161-1169
pubmed: 30104262
Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L135-44
pubmed: 27288488
Environ Mol Mutagen. 2014 Apr;55(3):196-208
pubmed: 24327377
Respir Res. 2008 Jul 15;9:53
pubmed: 18627612
J Allergy Clin Immunol. 2006 Jun;117(6):1396-403
pubmed: 16751003
J Cyst Fibros. 2013 Dec;12(6):623-9
pubmed: 23751406
Thorax. 2021 Oct;76(10):1010-1019
pubmed: 33846275
Rev Med Chil. 2018 Feb;146(2):168-174
pubmed: 29999152
Respir Res. 2017 Feb 23;18(1):39
pubmed: 28231834
Transl Res. 2012 Apr;159(4):205-17
pubmed: 22424425
Immunity. 2015 Oct 20;43(4):703-14
pubmed: 26431949
Thorax. 2014 Apr;69(4):363-70
pubmed: 24287167
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1964-70
pubmed: 11734453
J Immunol Methods. 2014 Feb;404:41-51
pubmed: 24370751
Metabolomics. 2016 Nov;12(11):
pubmed: 28845148
Am J Respir Cell Mol Biol. 2021 Jan;64(1):126-137
pubmed: 33095645
J Thorac Dis. 2020 Sep;12(9):4991-5019
pubmed: 33145073
Int J Environ Res Public Health. 2019 Nov 27;16(23):
pubmed: 31783619
Am J Physiol Lung Cell Mol Physiol. 2017 Feb 1;312(2):L288-L296
pubmed: 28011618
Curr Allergy Asthma Rep. 2017 Oct 5;17(11):79
pubmed: 28983782
Toxicol Sci. 2014 Jun;139(2):328-37
pubmed: 24675094
Eur Respir J. 2021 Jan 21;57(1):
pubmed: 33154031
J Interferon Cytokine Res. 2008 Mar;28(3):167-79
pubmed: 18338949
Toxicol In Vitro. 2018 Dec;53:29-36
pubmed: 30076938
Respir Res. 2012 Oct 03;13:89
pubmed: 23033980
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1175-1191
pubmed: 28642230
Pediatr Med. 2021 Feb;4:
pubmed: 34095814
J Allergy Clin Immunol. 2003 Aug;112(2):353-61
pubmed: 12897742
Am J Respir Crit Care Med. 2019 Apr 15;199(8):996-1007
pubmed: 30360637
Thorax. 1998 Nov;53(11):953-6
pubmed: 10193394
Physiol Rep. 2017 Aug;5(16):
pubmed: 28867672
Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C205-C214
pubmed: 31664858
Int J Mol Sci. 2014 Dec 03;15(12):22374-91
pubmed: 25479081
Environ Health Perspect. 2011 Apr;119(4):494-500
pubmed: 21147603
Sci Rep. 2021 Jun 25;11(1):13348
pubmed: 34172787